Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ruspharm is a Russian pharmaceutical company that specializes in the distribution and commercialization of high-tech medicines for the treatment of socially significant and rare diseases. The company's portfolio is centered on oncology, hematology, and orphan drugs, serving as a critical partner for international pharmaceutical firms seeking to enter the Russian market. Ruspharm manages the entire commercialization process, including regulatory registration, logistics, and specialized marketing. Additionally, through its consulting arm, the company provides clinical trial management and regulatory affairs services. By focusing on life-saving therapies, Ruspharm maintains a strong presence in the Russian state procurement and hospital sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ruspharm.